Fundraising Fox

Peter Fitzgerald

Investor

Managing Partner and Co-Founder at Triventures

US

About

Dr. Peter Fitzgerald is Co-founder and Managing Partner at Triventures, where he heads the US office. He serves as Director of the Center for Cardiovascular Technology at Stanford University Medical School and is Professor Emeritus in Stanford's Departments of Medicine and Engineering, working as an interventional cardiologist with a PhD in engineering. He previously co-founded LVP Capital in San Francisco, has founded 24 healthcare companies, and has consulted for the FDA on medical technology and digital health.

Contact· self-published, not guessed

Invests in

BiotechDigital HealthHealthtechMedical Devices

Investments

Board seats

ApicaCala HealthCathWorksDay Zero DiagnosticsFEMSelectGenooxHealthRevealMSTOrthospaceV-waveZingbox

Per the firm's website.

Colleagues at Triventures

Frequently asked questions

Who is Peter Fitzgerald?
Dr. Peter Fitzgerald is Co-founder and Managing Partner at Triventures, where he heads the US office. He serves as Director of the Center for Cardiovascular Technology at Stanford University Medical School and is Professor Emeritus in Stanford's Departments of Medicine and Engineering, working as an interventional cardiologist with a PhD in engineering. He previously co-founded LVP Capital in San Francisco, has founded 24 healthcare companies, and has consulted for the FDA on medical technology and digital health.
Where does Peter Fitzgerald work?
Peter Fitzgerald is Managing Partner and Co-Founder at Triventures.
What does Peter Fitzgerald invest in?
Peter Fitzgerald invests in Biotech, Digital Health, Healthtech, Medical Devices.
What boards does Peter Fitzgerald sit on?
Peter Fitzgerald holds tracked board seats at Apica, Cala Health, CathWorks, Day Zero Diagnostics, FEMSelect, Genoox, HealthReveal, MST, Orthospace, V-wave.